MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

GP130 receptor agonist-1

CAS No. : 339303-87-6

MCE 站：GP130 receptor agonist-1

产品活性：GP130 receptor agonist-1 是一种有效的、可透过血脑屏障并具有口服活性的 GP130 受体激动剂。GP130 receptor agonist-1 对 NMDA 诱导的神经毒性具有神经保护作用。

研究领域：Immunology/Inflammation

作用靶点：Interleukin Related

In Vitro: In SH-SY5Y cells, GP130 receptor agonist-1 (Compound 2) treatment showed a 2-fold increase in phosphorylation of STAT3 within 10 min at its regulatory Tyr705 site. In primary hippocampal neuronal cultures, the pSTAT3 levels are below levels of detection for GP130 receptor agonist-1 at all time points.
GP130 receptor agonist-1 treatment shows increases phosphorylation of AKT at its regulatory Thr308 site ａnd phosphorylation of ERK1/2 at its regulatory Thr202/Tyr204 site in the serum free media condition in SH-SY5Y cells, ａnd in primary cortical neurons.

In Vivo: For GP130 receptor agonist-1 (Compound 2), mice are dosed orally at 10 or 30 mg/kg, or injected subcutaneously (SQ) at 10 mg/kg, ａnd euthanized after 1, 2, 4, 6, ａnd 8 h post dose. At 2 h after SQ delivery at 10 mg/kg the brain Cmax is 161 ng/g while dosing at 30 mg/kg orally, results in the brain Cmax of 156 ng/g (0.57 μM). The brain to plasma ratio for 2 is ∼4:1 for oral 30 mg/kg ａnd ∼7.5:1 for 10 mg/kg SQ injection.

相关产品：Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Orally Active Compound Library  |  Neuroprotective Compound Library  |  Angiogenesis Related Compound Library  |  Resatorvid  |  Disulfiram  |  Deucravacitinib  |  Apilimod  |  Tocilizumab  |  APY0201  |  Diacerein  |  Vidofludimus  |  LMT-28  |  Muscone  |  Hydrocortisone hemisuccinate  |  RCGD423  |  SC144  |  Dupilumab  |  Neochlorogenic acid  |  Y-320  |  Ginsenoside Rh1  |  Semapimod tetrahydrochloride  |  AX-024  |  Ginsenoside Rc  |  Veledimex  |  VGX-1027  |  Mulberroside A  |  Pectolinarin  |  Madecassic acid  |  Methylthiouracil  |  Ustekinumab  |  YQ128

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。